US FDA GRANTS EUA TO GSK'S DRUG THAT TREATS MILD COVID-19 IN PEOPLE ABOVE 12

Highlights

• The GSK said this drug called VIR-7831 or Sotrovimab was cleared by the U.S. Food and Drug Administration for people ageing over 12 

According to the statement issued by drugmaker GSK, the US FDA has granted Emergency Use Authorisation to a drug called Sotrovimab developed by it along with Vir Biotech to  treat mild-to-moderate Covid-19 in high risk adults & paediatric patients.

The....